Amino Acid-Protecting Groups

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Chem. Rev. 2009, 109, 2455–2504 2455 Amino Acid-Protecting Groups Albert Isidro-Llobet,† Mercedes A´ lvarez,*,†,‡,§ and Fernando Albericio*,†,‡,| Institute for Research in Biomedicine, Barcelona Science Park, Baldiri Reixac 10, 08028 Barcelona, Spain; CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Barcelona Science Park, Baldiri Reixac 10, 08028 Barcelona, Spain; Laboratory of Organic Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, Spain; and Department of Organic Chemistry, University of Barcelona, Martı´ i Franque´s 1, 08028 Barcelona, Spain Received April 28, 2008 Contents 6.3.1. Protecting Groups Removed by Acid 2476 (Table 14) 1. Introduction 2456 6.3.2. Other Protecting Groups (Table 15) 2477 2. R-Amino 2457 7. Asparagine (Asn) and Glutamine (Gln) 2478 2.1. General 2457 7.1. General 2478 2.2. Introduction of the Protecting Groups 2457 7.2. Introduction of the Protecting Groups 2479 2.3. Removal 2457 7.3. Removal 2479 2.3.1. Protecting Groups Removed by Acid 2457 7.3.1. Protecting Groups Removed by Acid 2479 (Table 1) (Table 16) 2.3.2. Protecting Groups Removed by Base 2459 8. Arginine (Arg) 2480 (Table 2) 8.1. General 2480 2.3.3. Other Protecting Groups (Table 3) 2460 8.2. Introduction of the Protecting Groups 2480 3. Lysine (Lys), Ornithine (Orn), Diaminopropionic 2463 8.3. Removal 2480 Acid (Dap), and Diaminobutyric Acid (Dab) 8.3.1. Protecting Groups Removed by Acid 2480 3.1. General 2463 (Table 17) 3.2. Introduction of the Protecting Groups 2466 8.3.2. Protecting Groups Removed by Base 2481 3.3. Removal 2467 (Table 18) 3.3.1. Protecting Groups Removed by Acid 2467 8.3.3. Other Protecting Groups (Table 19) 2481 (Table 5) 9. Cysteine (Cys) 2481 3.3.2. Protecting Groups Removed by Base 2467 9.1. General 2481 (Table 6) 9.2. Introduction of the Protecting Groups 2481 3.3.3. Other Protecting Groups (Table 7) 2467 9.3. Removal 2483 4. R-Carboxylic Acid 2467 9.3.1. Protecting Groups Removed by Acid 2484 4.1. General 2467 (Table 20) 4.2. Introduction of the Protecting Groups 2468 9.3.2. Protecting Groups Removed by Base 2484 4.3. Removal 2468 (Table 21) 4.3.1. Protecting Groups Removed by Acid 2468 9.3.3. Other Protecting Groups (Table 22) 2484 (Table 8) 10. Methionine (Met) 2488 4.3.2. Protecting Groups Removed by Base 2469 10.1. General 2488 (Table 9) 10.2. Introduction of the Protecting Groups 2488 4.3.3. Other Protecting Groups (Table 10) 2470 10.3. Removal: Sulfoxide Reduction 2488 5. Aspartic (Asp) and Glutamic (Glu) Acids 2473 11. Histidine (His) 2489 Downloaded via UNIV OF GDANSK on November 19, 2019 at 12:26:11 (UTC). 5.1. General 2473 11.1. General 2489 5.2. Introduction of the Protecting Groups 2473 11.2. Introduction of the Protecting Groups 2489 5.3. Removal 2473 See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. 11.3. Removal 2489 5.3.1. Protecting Groups Removed by Acid 2473 (Table 11) 11.3.1. Protecting Groups Removed by Acid 2489 (Table 23) 5.3.2. Protecting Groups Removed by Base 2474 (Table 12) 11.3.2. Protecting Group Removed by Base 2491 (Table 24) 5.3.3. Other Protecting Groups (Table 13) 2474 11.3.3. Other Protecting Groups (Table 25) 2491 6. Amide Backbone 2476 12. Serine (Ser), Threonine (Thr), and Hydroxyproline 2492 6.1. General 2476 (Hyp) 6.2. Introduction of the Protecting Groups 2476 12.1. General 2492 6.3. Removal 2476 12.2. Introduction of the Protecting Groups 2493 12.3. Removal 2493 * To whom correspondence should be addressed. Fax: 34 93 403 71 26. 12.3.1. Protecting Groups Removed by Acid 2493 E-mail: [email protected]; [email protected]; † Institute for Research in Biomedicine. (Table 26) ‡ CIBER-BBN. 12.3.2. Other Protecting Groups (Table 27) 2493 § Laboratory of Organic Chemistry, Faculty of Pharmacy, University of 13. Tyrosine (Tyr) 2493 Barcelona. | Department of Organic Chemistry, University of Barcelona. 13.1. General 2493 10.1021/cr800323s CCC: $71.50 2009 American Chemical Society Published on Web 04/13/2009 2456 Chemical Reviews, 2009, Vol. 109, No. 6 Isidro-Llobet et al. 13.2. Introduction of the Protecting Groups 2495 13.3. Removal 2495 13.3.1. Protecting Groups Removed by Acid 2495 (Table 28) 13.3.2. Other Protecting Groups (Table 29) 2495 14. Tryptophan (Trp) 2497 14.1. General 2497 14.2. Introduction of the Protecting Groups 2497 14.3. Removal 2497 14.3.1. Protecting Groups Removed by Acid 2497 (Table 30) 14.3.2. Protecting Groups Removed by Base 2497 14.3.3. Other Protecting Groups (Table 31) 2497 15. Abbreviations 2497 16. Acknowledgments 2498 Albert Isidro-Llobet was born in El Prat de Llobregat (Spain) in 1981. He studied Chemistry at the University of Barcelona (Spain) and obtained 17. References 2498 his Ph.D. in 2008 at the Barcelona Science Park (University of Barcelona) under the supervision of Professors Fernando Albericio and Mercedes 1. Introduction A´lvarez. His Ph.D. work involved the development of new protecting groups for the synthesis of complex peptides. In October 2008, he moved to Dr. Synthetic organic chemistry is based on the concourse of David R. Spring’s group at the University of Cambridge (U.K.) where he reagents and catalysts to achieve the clean formation of new is currently a postdoctoral fellow working in Diversity Oriented Synthesis bonds, and appropriate protecting groups are required to of small molecules as antibiotics. His research interests include the prevent the formation of undesired bonds and side reactions.1,2 development of new methodologies for solid- and solution-phase peptide Thus, a promising synthetic strategy can be jeopardized if synthesis and the research for new bioactive compounds. the corresponding protecting groups are not properly chosen. Emil Fischer was possibly the first to recognize the need to temporally mask a functional group to allow regioselective bond formation in the synthesis of carbohydrates.3 However, the first “modern” protecting group was the benzylozycar- bonyl (Z) developed by Bergmann and Zervas.4 Z fits with Mercedes A´ lvarez received her Ph.D. in Chemistry from the University of Barcelona under the supervision of Prof. Ricardo Granados. She has a permanent position in the University of Barcelona as Associate Professor in the Faculty of Pharmacy. In 1990, she spent a sabbatical year in The Manchester University working with Prof. John A. Joule. After that period, she started a long collaboration between Manchester and Barcelona Universities for developing new procedures for the synthesis of marine Professor Fernando Albericio was born in Barcelona, Spain, in 1953. He natural products with polyheterocyclic structure and biological activities. received his Ph.D. in Chemistry at the University of Barcelona, in 1981. In 2002, she was invited to joint with the group led by Prof. Fernando Following postdoctoral work at Tufts University (Boston), at the Universite´ Albericio and to move her research group to the Science Parc of d’Aix-Marseille (France), and at the University of Minnesota (1981-1984), Barcelona. Currently, she holds a double appointment as Professor at he returned to Barcelona as Associate Professor. During the 1992- 1994 the University of Barcelona and Researcher at the Barcelona Biomedical period, he was Director of Peptide Research with Milligen/Biosearch in Research Institute in the Barcelona Science Park. Her major research Boston. He rejoined the University of Barcelona, where he was promoted interests cover synthesis of natural products, heterocyclic chemistry, to professor in 1995. Nowadays, he is holding various appointments: combinatorial chemistry, and solid-phase methodology, as well as synthesis General Director of the Barcelona Science Park, Professor at the University of small molecules with therapeutic activities. of Barcelona, and Group Leader at the Institute for Research in Biomedi- cine. Professor Albericio’s major research interests cover practically all the main characteristics associated with a protecting group: aspects of peptide synthesis and combinatorial chemistry methodologies, as well as synthesis of peptides and small molecules with therapeutic (i) it is easily introduced into the functional group; (ii) it is activities. He has published over 500 papers, several review articles, and stable to a broad range of reaction conditions; and (iii) it is 22 patents, and he is coauthor of 3 books. He is editor of several scientific safely removed at the end of the synthetic process or when journals and acts in the editorial board of several others. In addition, the functional group requires manipulation. Another corner- professor Albericio is deeply involved in the development of the third stone in this field was when Barany et al.5,6 described the mission of the University, the transference of knowledge and technology orthogonality to society. He has founded several biotech companies and is acting in concept of , in the sense that the two or more the board of directors of several foundations and companies. Furthermore, protecting groups belong to independent classes and are he is consultant for several companies in the chemical and pharmaceutical removed by distinct mechanisms. The groups can be re- areas. moved,therefore,in any order and in the presence of the rest. Amino Acid-Protecting Groups Chemical Reviews, 2009, Vol. 109, No. 6 2457 Orthogonal protection schemes are usually milder because selective deprotection is governed by alternative cleavage mechanisms rather than by reaction rates. Since the pio- neernig work of Bergmann and Zervas, the development of new protecting groups has been deeply tied to peptide chemistry. Protection is totally mandatory for the construction of these polyfunctional molecules, which contain up to eight distinct functional groups in addition to indole and imidazole rings, which should also be protected.
Recommended publications
  • Modifications on the Basic Skeletons of Vinblastine and Vincristine

    Modifications on the Basic Skeletons of Vinblastine and Vincristine

    Molecules 2012, 17, 5893-5914; doi:10.3390/molecules17055893 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Modifications on the Basic Skeletons of Vinblastine and Vincristine Péter Keglevich, László Hazai, György Kalaus and Csaba Szántay * Department of Organic Chemistry and Technology, University of Technology and Economics, H-1111 Budapest, Szt. Gellért tér 4, Hungary * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel: +36-1-463-1195; Fax: +36-1-463-3297. Received: 30 March 2012; in revised form: 9 May 2012 / Accepted: 10 May 2012 / Published: 18 May 2012 Abstract: The synthetic investigation of biologically active natural compounds serves two main purposes: (i) the total synthesis of alkaloids and their analogues; (ii) modification of the structures for producing more selective, more effective, or less toxic derivatives. In the chemistry of dimeric Vinca alkaloids enormous efforts have been directed towards synthesizing new derivatives of the antitumor agents vinblastine and vincristine so as to obtain novel compounds with improved therapeutic properties. Keywords: antitumor therapy; vinblastine; vincristine; derivatives 1. Introduction Vinblastine (1) and vincristine (2) are dimeric alkaloids (Figure 1) isolated from the Madagaskar periwinkle plant (Catharantus roseus), exhibit significant cytotoxic activity and are used in the antitumor therapy as antineoplastic agents. In the course of cell proliferation they act as inhibitors during the metaphase of the cell cycle and by binding to the microtubules inhibit the development of the mitotic spindle. In tumor cells these agents inhibit the DNA repair and the RNA synthesis mechanisms, blocking the DNA-dependent RNA polymerase. Molecules 2012, 17 5894 Figure 1.
  • Carbamate Pesticides Aldicarb Aldicarb Sulfoxide Aldicarb Sulfone

    Carbamate Pesticides Aldicarb Aldicarb Sulfoxide Aldicarb Sulfone

    Connecticut General Statutes Sec 19a-29a requires the Commissioner of Public Health to annually publish a list setting forth all analytes and matrices for which certification for testing is required. Connecticut ELCP Drinking Water Analytes Revised 05/31/2018 Microbiology Total Coliforms Fecal Coliforms/ E. Coli Carbamate Pesticides Legionella Aldicarb Cryptosporidium Aldicarb Sulfoxide Giardia Aldicarb Sulfone Carbaryl Physicals Carbofuran Turbidity 3-Hydroxycarbofuran pH Methomyl Conductivity Oxamyl (Vydate) Minerals Chlorinated Herbicides Alkalinity, as CaCO3 2,4-D Bromide Dalapon Chloride Dicamba Chlorine, free residual Dinoseb Chlorine, total residual Endothall Fluoride Picloram Hardness, Calcium as Pentachlorophenol CaCO3 Hardness, Total as CaCO3 Silica Chlorinated Pesticides/PCB's Sulfate Aldrin Chlordane (Technical) Nutrients Dieldrin Endrin Ammonia Heptachlor Nitrate Heptachlor Epoxide Nitrite Lindane (gamma-BHC) o-Phosphate Metolachlor Total Phosphorus Methoxychlor PCB's (individual aroclors) Note 1 PCB's (as decachlorobiphenyl) Note 1 Demands Toxaphene TOC Nitrogen-Phosphorus Compounds Alachlor Metals Atrazine Aluminum Butachlor Antimony Diquat Arsenic Glyphosate Barium Metribuzin Beryllium Paraquat Boron Propachlor Cadmium Simazine Calcium Chromium Copper SVOC's Iron Benzo(a)pyrene Lead bis-(2-ethylhexyl)phthalate Magnesium bis-(ethylhexyl)adipate Manganese Hexachlorobenzene Mercury Hexachlorocyclopentadiene Molybdenum Nickel Potassium Miscellaneous Organics Selenium Dibromochloropropane (DBCP) Silver Ethylene Dibromide (EDB)
  • IV (Advance Organic Synthesis and Supramolecular Chemistry and Carbocyclic Rings) Module No and 9: Protection and Deprotection Title Module Tag CHE P14 M9

    IV (Advance Organic Synthesis and Supramolecular Chemistry and Carbocyclic Rings) Module No and 9: Protection and Deprotection Title Module Tag CHE P14 M9

    Subject Chemistry Paper No and Title 14: Organic Chemistry –IV (Advance Organic Synthesis and Supramolecular Chemistry and carbocyclic rings) Module No and 9: Protection and deprotection Title Module Tag CHE_P14_M9 CHEMISTRY Paper No. 14: Organic Chemistry –IV (Advance Organic Synthesis and Supramolecular Chemistry and carbocyclic rings) Module No. 9: Protection and deprotection Table of Content 1. Learning outcomes 2. Introduction 3. Protecting groups for carbonyl compounds 4. Protecting groups for alcohols 5. Protecting groups for amines 6. Summary CHEMISTRY Paper No. 14: Organic Chemistry –IV (Advance Organic Synthesis and Supramolecular Chemistry and carbocyclic rings) Module No. 9: Protection and deprotection 1. Learning Outcomes After studying this module, you shall be able to Know about protecting groups. Study the characteristics of protecting groups. Understand the functional group protection. Know the protection of important functional groups. 2. Introduction Protection and deprotection is an important part of organic synthesis. During the course of synthesis, we many times desire to perform reaction at only one of the two functional groups in any single organic molecules. For example, in an organic compound possessing two functional groups like ester and ketone, we have to perform reaction at only ester group, them the keto group needs to be protected. If we want to reduce the ester group, then keto group will also get reduced. To avoid this type of complications, protection and deprotection of functional groups are necessary. 3. Protecting groups for carbonyl compounds The protecting groups allow the masking of a particular functional group where a specified reaction is not to be performed. The protection is required as it interferes with another reaction.
  • WO 2018/005077 Al O O© O

    WO 2018/005077 Al O O© O

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/005077 Al 04 January 2018 (04.01.2018) W ! P O PCT (51) International Patent Classification: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, A61K 31/78 (2006.01) C08J 7/04 (2006.01) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. C08G 59/77 (2006.01) (84) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of regional protection available): ARIPO (BW, GH, PCT/US20 17/037 176 GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (22) International Filing Date: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 13 June 2017 (13.06.2017) EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (25) Filing Language: English MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (26) Publication Language: English KM, ML, MR, NE, SN, TD, TG). (30) Priority Data: 62/356,918 30 June 2016 (30.06.2016) US Published: — with international search report (Art. 21(3)) (71) Applicant: ELEMENTIS SPECIALTIES, INC. [US/US]; 469 Old Trenton Road, East Windsor, NJ 085 12 (US). (72) Inventors: IJDO, Wouter; 1224 Bridle Estates Dri ve, Yardley, PA 19067 (US). CHEN, Yanhui; 4 Hal- stead Place, Princeton, NJ 08540 (US).
  • A Global Review on Short Peptides: Frontiers and Perspectives †

    A Global Review on Short Peptides: Frontiers and Perspectives †

    molecules Review A Global Review on Short Peptides: Frontiers and Perspectives † Vasso Apostolopoulos 1 , Joanna Bojarska 2,* , Tsun-Thai Chai 3 , Sherif Elnagdy 4 , Krzysztof Kaczmarek 5 , John Matsoukas 1,6,7, Roger New 8,9, Keykavous Parang 10 , Octavio Paredes Lopez 11 , Hamideh Parhiz 12, Conrad O. Perera 13, Monica Pickholz 14,15, Milan Remko 16, Michele Saviano 17, Mariusz Skwarczynski 18, Yefeng Tang 19, Wojciech M. Wolf 2,*, Taku Yoshiya 20 , Janusz Zabrocki 5, Piotr Zielenkiewicz 21,22 , Maha AlKhazindar 4 , Vanessa Barriga 1, Konstantinos Kelaidonis 6, Elham Mousavinezhad Sarasia 9 and Istvan Toth 18,23,24 1 Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia; [email protected] (V.A.); [email protected] (J.M.); [email protected] (V.B.) 2 Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland 3 Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; [email protected] 4 Botany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt; [email protected] (S.E.); [email protected] (M.A.) 5 Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland; [email protected] (K.K.); [email protected] (J.Z.) 6 NewDrug, Patras Science Park, 26500 Patras, Greece; [email protected] 7 Department of Physiology and Pharmacology,
  • Benzyl Ligand† Cite This: Chem

    Benzyl Ligand† Cite This: Chem

    ChemComm View Article Online COMMUNICATION View Journal | View Issue Homoleptic organolanthanide compounds supported by the bis(dimethylsilyl)benzyl ligand† Cite this: Chem. Commun., 2017, 53,716 Kasuni C. Boteju, Arkady Ellern and Aaron D. Sadow* Received 21st November 2016, Accepted 12th December 2016 DOI: 10.1039/c6cc09304c www.rsc.org/chemcomm À A b-SiH functionalized benzyl anion [C(SiHMe2)2Ph] is obtained by A strategy for stabilizing coordinatively unsaturated rare earth deprotonation of HC(SiHMe2)2Ph with KCH2Ph or by reaction of amides has involved the incorporation of SiH groups, which 14 KOtBu and (Me2HSi)3CPh; LnI3(THF)n and three equivalents of this form labile secondary interactions with the lanthanide center. carbanion combine to provide homoleptic tris(alkyl)lanthanide Furthermore, the SiH moiety provides a powerful signature in 1 29 Creative Commons Attribution 3.0 Unported Licence. compounds Ln{C(SiHMe2)2Ph}3 (Ln = La, Ce, Pr, Nd) containing Hand Si NMR and IR spectra. This b-SiH strategy may also be secondary metal–ligand interactions. applied to alkyls, and the ligand C(SiHMe2)3 supports trivalent yttrium and divalent ytterbium and samarium homoleptic alkyls Synthesis of homoleptic organolanthanide complexes, particu- containing secondary Ln(H–Si interactions.15,16 Recently, we larly those of the early trivalent lanthanides (La–Nd), is challenging reported Ce{C(SiHMe2)3}3 as a precursor to a zwitterionic hydro- due to the large radii of these elements, polar bonding, high silylation catalyst.17 New chemistry might be accessed with alkyl charge, and high Lewis acidity.1 Such homoleptic compounds ligand variations that include both b-SiH and benzylic function- should be valuable for the synthesis of new catalysts and alities, and these groups could compete to enhance the homo- new materials,2 yet solvent- or donor-group-free, salt-free, and leptic compounds’ resistance to undesired ligand elimination This article is licensed under a thermally robust organolanthanide compounds are not readily pathways.
  • Ganic Compounds

    Ganic Compounds

    6-1 SECTION 6 NOMENCLATURE AND STRUCTURE OF ORGANIC COMPOUNDS Many organic compounds have common names which have arisen historically, or have been given to them when the compound has been isolated from a natural product or first synthesised. As there are so many organic compounds chemists have developed rules for naming a compound systematically, so that it structure can be deduced from its name. This section introduces this systematic nomenclature, and the ways the structure of organic compounds can be depicted more simply than by full Lewis structures. The language is based on Latin, Greek and German in addition to English, so a classical education is beneficial for chemists! Greek and Latin prefixes play an important role in nomenclature: Greek Latin ½ hemi semi 1 mono uni 1½ sesqui 2 di bi 3 tri ter 4 tetra quadri 5 penta quinque 6 hexa sexi 7 hepta septi 8 octa octo 9 ennea nona 10 deca deci Organic compounds: Compounds containing the element carbon [e.g. methane, butanol]. (CO, CO2 and carbonates are classified as inorganic.) See page 1-4. Special characteristics of many organic compounds are chains or rings of carbon atoms bonded together, which provides the basis for naming, and the presence of many carbon- hydrogen bonds. The valency of carbon in organic compounds is 4. Hydrocarbons: Compounds containing only the elements C and H. Straight chain hydrocarbons are named according to the number of carbon atoms: CH4, methane; C2H6 or H3C-CH3, ethane; C3H8 or H3C-CH2-CH3, propane; C4H10 or H3C-CH2- CH2-CH3, butane; C5H12 or CH3CH2CH2CH2CH3, pentane; C6H14 or CH3(CH2)4CH3, hexane; C7H16, heptane; C8H18, octane; C9H20, nonane; C10H22, CH3(CH2)8CH3, decane.
  • N-Methyl Carbamate Cumulative Risk Assessment: Pilot Cumulative Analysis

    N-Methyl Carbamate Cumulative Risk Assessment: Pilot Cumulative Analysis

    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF PREVENTION, PESTICIDES, AND TOXIC SUBSTANCES April 15, 2005 MEMORANDUM SUBJECT: Transmittal of Meeting Minutes of the FIFRA Scientific Advisory Panel Meeting Held February 15 - 18, 2005 on the N-methyl Carbamate Cumulative Risk Assessment: Pilot Cumulative Analysis TO: James J. Jones, Director Office of Pesticide Programs FROM: Myrta R. Christian, Designated Federal Official Joseph E. Bailey, Designated Federal Official FIFRA Scientific Advisory Panel Office of Science Coordination and Policy THRU: Larry C. Dorsey, Executive Secretary FIFRA Scientific Advisory Panel Office of Science Coordination and Policy Clifford J. Gabriel, Director Office of Science Coordination and Policy Attached, please find the meeting minutes of the FIFRA Scientific Advisory Panel open meeting held in Arlington, Virginia on February 15 - 18, 2005. This report addresses a set of scientific issues being considered by the Environmental Protection Agency pertaining to the N- methyl carbamate cumulative risk assessment: pilot cumulative analysis. Attachment 1 of 113 cc: Susan Hazen Margaret Schneider Anne Lindsay Margie Fehrenbach Janet Andersen Debbie Edwards Steven Bradbury William Diamond Arnold Layne Tina Levine Lois Rossi Frank Sanders Richard Keigwin Randolph Perfetti William Jordan Douglas Parsons Enesta Jones Vanessa Vu (SAB) Anna Lowit David J. Miller Nelson Thurman Dirk Young David Hrdy Jeff Evans Steve Nako Stephanie Padilla R. Woodrow Setzer Ginger Moser Miles Okino Jerry Blancato Fred Power Curtis Dary Tom Nolan, USGS OPP Docket 2 of 113 FIFRA Scientific Advisory Panel Members Stephen M. Roberts, Ph.D. (Chair of the FIFRA SAP) Janice E. Chambers, Ph.D. H. Christopher Frey, Ph.D.
  • Mann Et Al. Text 22

    Mann Et Al. Text 22

    Catalytic Z-Selective Cross-Metathesis with Secondary Silyl- and Benzyl-Protected Allylic Ethers: Mechanistic Aspects and Applications to Natural Product Synthesis The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Mann, Tyler J., Alexander W. H. Speed, Richard R. Schrock, and Amir H. Hoveyda. “Catalytic Z-Selective Cross-Metathesis with Secondary Silyl- and Benzyl-Protected Allylic Ethers: Mechanistic Aspects and Applications to Natural Product Synthesis.” Angewandte Chemie International Edition 52, no. 32 (August 5, 2013): 8395-8400. As Published http://dx.doi.org/10.1002/anie.201302538 Publisher Wiley Blackwell Version Original manuscript Citable link http://hdl.handle.net/1721.1/84085 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike 3.0 Detailed Terms http://creativecommons.org/licenses/by-nc-sa/3.0/ Catalytic Z-Selective Cross-Metathesis with Secondary Silyl- and Benzyl-Protected Allylic Ethers: Mechanistic Aspects and Applications to Natural Product Synthesis** Tyler J. Mann, Alexander W. H. Speed, Richard R. Schrock and Amir H. Hoveyda* [*] Prof. A. H. Hoveyda, T. J. Mann, Dr. A. W. H. Speed Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA 02467 (USA) Fax: (1) 617-552-1442 E-mail: [email protected] Prof. R. R. Schrock Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139 (USA) [**] Financial support was provided by the NIH (GM-59426). We are grateful to Robert V. O’Brien
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0082079 A1 Spetzler Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2011/0082079 A1 Spetzler Et Al

    US 2011 0082079A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0082079 A1 Spetzler et al. (43) Pub. Date: Apr. 7, 2011 (54) GLUCAGON-LIKE PEPTDE-1 DERVATIVES Publication Classification AND THEIR PHARMACEUTICAL USE (51) Int. Cl. A638/22 (2006.01) (75) Inventors: Jane Spetzler, Bronsho (DK); C07K I4/575 (2006.01) Lauge Schäffer, Lyngby (DK); A6IP3/10 (2006.01) Jesper Lau, Farum (DK); Thomas A6IP 9/12 (2006.01) Kruse, Herlev (DK); Patrick A6IP3/04 (2006.01) William Garibay, Holte (DK); A6IP 9/10 (2006.01) Steffen Runge, Frederiksberg A6IPI/00 (2006.01) (DK); Henning Thogersen, Farum A6IPL/04 (2006.01) (DK); Ingrid Petersson, Frederiksberg (DK) (52) U.S. Cl. .......................... 514/7.2:530/399; 514/11.7 (57) ABSTRACT (73) Assignee: Novo Nordisk A/S, Bagsvard (DK) The invention relates to protracted Glucagon-Like Peptide-1 Appl. No.: (GLP-1) derivatives and therapeutic uses thereof. The GLP-1 (21) 12/676,451 derivative of the invention comprises a modified GLP-1 (7- PCT Fled: 37) sequence having a total of 2-12 amino acid modifications, (22) Sep. 5, 2008 including Glu22 and Arg26, and being derivatised with an PCT NO.: PCT/EP2008/061755 albumin binding residue or pegylated in position 18, 20, 23. (86) 30, 31, 34, 36, 37, or 39. These compounds are useful in the S371 (c)(1), treatment or prevention of diabetes type 2 and related dis (2), (4) Date: Oct. 13, 2010 eases. The compounds are potent, stable, have long half-lives, a high affinity of binding to albumin, and/or a high affinity of (30) Foreign Application Priority Data binding to the extracellular domain of the GLP-1 receptor (GLP-1R), all of which is of potential relevance for the overall Sep.
  • Chapter 3. the Concept of Protecting Functional Groups

    Chapter 3. the Concept of Protecting Functional Groups

    Chapter 3. The Concept of Protecting Functional Groups When a chemical reaction is to be carried out selectively at one reactive site in a multifunctional compound, other reactive sites must be temporarily blocked. A protecting group must fulfill a number of requirements: • The protecting group reagent must react selectively (kinetic chemoselectivity) in good yield to give a protected substrate that is stable to the projected reactions. • The protecting group must be selectively removed in good yield by readily available reagents. • The protecting group should not have additional functionality that might provide additional sites of reaction. 3.1 Protecting of NH groups Primary and secondary amines are prone to oxidation, and N-H bonds undergo metallation on exposure to organolithium and Grignard reagents. Moreover, the amino group possesses a lone pair electrons, which can be protonated or reacted with electrophiles. To render the lone pair electrons less reactive, the amine can be converted into an amide via acylation. N-Benzylamine Useful for exposure to organometallic reagents or metal hydrides Hydrogenolysis Benzylamines are not cleaved by Lewis acid Pearlman’s catalyst Amides Basicity of nitrogen is reduced, making them less susceptible to attack by electrophilic reagent The group is stable to pH 1-14, nucleophiles, organometallics (except organolithium reagents), catalytic hydrogenation, and oxidation. Cleaved by strong acid (6N HCl, HBr) or diisobutylaluminum hydride Carbamates Behave like a amides, hence no longer act as nucleophile Stable to oxidizing agents and aqueous bases but may react with reducing agents. Iodotrimethylsilane is often the reagent for removal of this protecting group Stable to both aqueous acid and base Benzoyloxycarbonyl group for peptide synthesis t-butoxycarbonyl group(Boc) is inert to hydrogenolysis and resistant to bases and nucleophilic reagent.
  • A General Protocol for the Formal Total Synthesis of (±)‐Strychnine A

    A General Protocol for the Formal Total Synthesis of (±)‐Strychnine A

    Angewandte Communications Chemie International Edition:DOI:10.1002/anie.201611734 Annulations German Edition:DOI:10.1002/ange.201611734 Reaction of Donor-Acceptor Cyclobutanes with Indoles:AGeneral Protocol for the Formal Total Synthesis of ( )-Strychnine and the Total Synthesis of ( )-Akuammicine Æ Æ Liang-Wen Feng+,Hai Ren+,HuXiong,Pan Wang,Lijia Wang,* and Yong Tang* Abstract: Aligand-promoted catalytic [4+2] annulation reaction using indole derivatives and donor-acceptor (D-A) cyclobutanes is reported, thus providing an efficient and atom- economical access to versatile cyclohexa-fused indolines with excellent levels of diastereoselectivity and abroad substrate scope.Inthe presence of achiral SaBOXligand, excellent enantioselectivity was realized with up to 94%ee. This novel synthetic method is applied as ageneral protocol for the total synthesis of ( )-akuammicine and the formal total synthesis of Æ ( )-strychninefrom the same common-core scaffold. Æ Owing to their synthetic potential of accessing various cyclic compounds by formal [4 + n] cycloadditions,donor- acceptor (D-A) cyclobutanes have attracted increasing atten- Scheme 1. Anew route to access strychnos alkaloids. PG= protecting tion in recent years.[1,2] In 2013, Matsuo et al. reported an group, PMB =p-methoxybenzyl. elegant regioselective inter-and intramolecular formal [4+2] cycloaddition of cyclobutanones with indoles in 31–98% [a] yields with moderate to good diastereoselectivities.[2i] In 2016, Table 1: Reaction optimization. we demonstrated ahighly efficient formal